Xiaolin Luo

Xiaolin Luo is an accomplished pharmacology professional with significant experience in oncology research and drug development. Currently serving as Associate Director at Enlaza Therapeutics since November 2021, Xiaolin previously held the position of Assistant Director at Ionis Pharmaceuticals, where leadership involved guiding teams in identifying and advancing novel cancer therapeutic targets and improving ASO drug delivery methods. Prior roles include Senior Scientist and Assistant Project Scientist at UC San Diego, focusing on NASH-driven liver tumorigenesis through innovative sequencing and proteomics approaches. Xiaolin holds a Ph.D. in Biochemistry and Molecular Biology from the Shanghai Institutes for Biological Sciences and an MBA Certificate from the Rady School of Management at UC San Diego.